lifestyle spending accounts glp-1 prescriptions weight management reimbursement The future of GLP-1s: Cost, access and more trends HR must know CMS Issues Coverage Guidance on
Description
Lilly announced the topline results from its phase 3b "TOGETHER PsA" trial, showing that the combination use of ixekizumab (Taltz) and tirzepatide (Zepbound) was superior to IXE alone, yielding both significant weight loss and ACR50 disease control in adults with active psoriatic arthritis (PsA).
Learn what to expect and how lifestyle habits can help maintain your results....
CLEAN TASTE: Allulose granules taste very similar to sugar and is 70% as sweet as sugar
Read more in Crohns & Colitis 360:
The goal is to support fat loss and muscle health
Semaglutide (Ozempic)
